PRA Health Sciences Receivables

PRA Health Sciences (PRAH) currently reports a receivables of $780M as of March 2021. That compares with $690M in the prior-year period — up 12.6% year over year. Use the charts on this page to explore PRA Health Sciences's receivables history and peer comparisons.

PRA Health Sciences's receivables increased from $690M to $780M — a 12.6% year-over-year increase (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PRA Health Sciences reported $780M in receivables as of March 2021. That compares with $690M in the prior-year period — up 12.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $780M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PRA Health Sciences, and consider following PRAH for alerts when major investors trade the stock.

PRA Health Sciences is classified in the Healthcare sector. On receivables, it currently shows $780M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRAH with unrelated industries.